vs
GATX CORP（GATX）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
Revvity的季度营收约是GATX CORP的1.7倍（$772.1M vs $449.0M），GATX CORP净利率更高（21.6% vs 12.7%，领先8.9%），GATX CORP同比增速更快（8.6% vs 5.9%），过去两年Revvity的营收复合增速更高（9.0% vs 8.7%）
GATX公司总部位于美国伊利诺伊州芝加哥，是全球知名的轨道车辆租赁服务商，业务覆盖北美、欧洲、亚洲，旗下拥有近15万辆轨道车辆，涵盖罐车、货运车厢、机车等品类。此外，公司与罗尔斯·罗伊斯合资持有规模领先的飞机备用发动机租赁资产组合，主要服务石油等行业客户。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
GATX vs RVTY — 直观对比
营收规模更大
RVTY
是对方的1.7倍
$449.0M
营收增速更快
GATX
高出2.7%
5.9%
净利率更高
GATX
高出8.9%
12.7%
两年增速更快
RVTY
近两年复合增速
8.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $449.0M | $772.1M |
| 净利润 | $97.0M | $98.4M |
| 毛利率 | — | — |
| 营业利润率 | 15.6% | 14.5% |
| 净利率 | 21.6% | 12.7% |
| 营收同比 | 8.6% | 5.9% |
| 净利润同比 | 26.8% | 3.9% |
| 每股收益（稀释后） | $2.66 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收GATXRVTY
| Q4 25 | $449.0M | $772.1M | ||
| Q3 25 | $439.3M | $698.9M | ||
| Q2 25 | $430.5M | $720.3M | ||
| Q1 25 | $421.6M | $664.8M | ||
| Q4 24 | $413.5M | $729.4M | ||
| Q3 24 | $405.4M | $684.0M | ||
| Q2 24 | $386.7M | $691.7M | ||
| Q1 24 | $379.9M | $649.9M |
净利润GATXRVTY
| Q4 25 | $97.0M | $98.4M | ||
| Q3 25 | $82.2M | $46.7M | ||
| Q2 25 | $75.5M | $53.9M | ||
| Q1 25 | $78.6M | $42.2M | ||
| Q4 24 | $76.5M | $94.6M | ||
| Q3 24 | $89.0M | $94.4M | ||
| Q2 24 | $44.4M | $55.4M | ||
| Q1 24 | $74.3M | $26.0M |
毛利率GATXRVTY
| Q4 25 | — | — | ||
| Q3 25 | — | 53.6% | ||
| Q2 25 | — | 54.5% | ||
| Q1 25 | — | 56.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 56.3% | ||
| Q2 24 | — | 55.7% | ||
| Q1 24 | — | 54.6% |
营业利润率GATXRVTY
| Q4 25 | 15.6% | 14.5% | ||
| Q3 25 | 13.3% | 11.7% | ||
| Q2 25 | 18.7% | 12.6% | ||
| Q1 25 | 16.6% | 10.9% | ||
| Q4 24 | 14.6% | 16.3% | ||
| Q3 24 | 21.1% | 14.3% | ||
| Q2 24 | 10.9% | 12.4% | ||
| Q1 24 | 19.3% | 6.8% |
净利率GATXRVTY
| Q4 25 | 21.6% | 12.7% | ||
| Q3 25 | 18.7% | 6.7% | ||
| Q2 25 | 17.5% | 7.5% | ||
| Q1 25 | 18.6% | 6.4% | ||
| Q4 24 | 18.5% | 13.0% | ||
| Q3 24 | 22.0% | 13.8% | ||
| Q2 24 | 11.5% | 8.0% | ||
| Q1 24 | 19.6% | 4.0% |
每股收益（稀释后）GATXRVTY
| Q4 25 | $2.66 | $0.86 | ||
| Q3 25 | $2.25 | $0.40 | ||
| Q2 25 | $2.06 | $0.46 | ||
| Q1 25 | $2.15 | $0.35 | ||
| Q4 24 | $2.11 | $0.77 | ||
| Q3 24 | $2.43 | $0.77 | ||
| Q2 24 | $1.21 | $0.45 | ||
| Q1 24 | $2.03 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $743.0M | $919.9M |
| 总债务越低越好 | $12.5B | — |
| 股东权益账面价值 | $2.8B | $7.3B |
| 总资产 | $18.0B | $12.2B |
| 负债/权益比越低杠杆越低 | 4.55× | — |
8季度趋势，按日历期对齐
现金及短期投资GATXRVTY
| Q4 25 | $743.0M | $919.9M | ||
| Q3 25 | $696.1M | $931.4M | ||
| Q2 25 | $754.6M | $991.8M | ||
| Q1 25 | $757.2M | $1.1B | ||
| Q4 24 | $401.6M | $1.2B | ||
| Q3 24 | $503.7M | $1.2B | ||
| Q2 24 | $823.6M | $2.0B | ||
| Q1 24 | $479.1M | $1.7B |
总债务GATXRVTY
| Q4 25 | $12.5B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $8.3B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益GATXRVTY
| Q4 25 | $2.8B | $7.3B | ||
| Q3 25 | $2.7B | $7.4B | ||
| Q2 25 | $2.7B | $7.6B | ||
| Q1 25 | $2.5B | $7.6B | ||
| Q4 24 | $2.4B | $7.7B | ||
| Q3 24 | $2.4B | $7.9B | ||
| Q2 24 | $2.3B | $7.9B | ||
| Q1 24 | $2.3B | $7.8B |
总资产GATXRVTY
| Q4 25 | $18.0B | $12.2B | ||
| Q3 25 | $13.3B | $12.1B | ||
| Q2 25 | $13.2B | $12.4B | ||
| Q1 25 | $13.0B | $12.4B | ||
| Q4 24 | $12.3B | $12.4B | ||
| Q3 24 | $12.4B | $12.8B | ||
| Q2 24 | $12.2B | $13.4B | ||
| Q1 24 | $11.6B | $13.4B |
负债/权益比GATXRVTY
| Q4 25 | 4.55× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 3.39× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $144.3M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | — | $161.8M |
| 自由现金流率自由现金流/营收 | — | 21.0% |
| 资本支出强度资本支出/营收 | — | 2.6% |
| 现金转化率经营现金流/净利润 | 1.49× | 1.85× |
| 过去12个月自由现金流最近4个季度 | — | $509.4M |
8季度趋势，按日历期对齐
经营现金流GATXRVTY
| Q4 25 | $144.3M | $182.0M | ||
| Q3 25 | $218.3M | $138.5M | ||
| Q2 25 | $161.3M | $134.3M | ||
| Q1 25 | $124.2M | $128.2M | ||
| Q4 24 | $206.0M | $174.2M | ||
| Q3 24 | $160.2M | $147.9M | ||
| Q2 24 | $138.3M | $158.6M | ||
| Q1 24 | $97.6M | $147.6M |
自由现金流GATXRVTY
| Q4 25 | — | $161.8M | ||
| Q3 25 | — | $120.0M | ||
| Q2 25 | — | $115.5M | ||
| Q1 25 | — | $112.2M | ||
| Q4 24 | — | $149.8M | ||
| Q3 24 | — | $125.6M | ||
| Q2 24 | — | $136.6M | ||
| Q1 24 | — | $129.7M |
自由现金流率GATXRVTY
| Q4 25 | — | 21.0% | ||
| Q3 25 | — | 17.2% | ||
| Q2 25 | — | 16.0% | ||
| Q1 25 | — | 16.9% | ||
| Q4 24 | — | 20.5% | ||
| Q3 24 | — | 18.4% | ||
| Q2 24 | — | 19.7% | ||
| Q1 24 | — | 20.0% |
资本支出强度GATXRVTY
| Q4 25 | — | 2.6% | ||
| Q3 25 | — | 2.6% | ||
| Q2 25 | — | 2.6% | ||
| Q1 25 | — | 2.4% | ||
| Q4 24 | — | 3.4% | ||
| Q3 24 | — | 3.3% | ||
| Q2 24 | — | 3.2% | ||
| Q1 24 | — | 2.7% |
现金转化率GATXRVTY
| Q4 25 | 1.49× | 1.85× | ||
| Q3 25 | 2.66× | 2.97× | ||
| Q2 25 | 2.14× | 2.49× | ||
| Q1 25 | 1.58× | 3.03× | ||
| Q4 24 | 2.69× | 1.84× | ||
| Q3 24 | 1.80× | 1.57× | ||
| Q2 24 | 3.11× | 2.87× | ||
| Q1 24 | 1.31× | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
GATX
| Rail North America | $300.9M | 67% |
| Rail International | $104.1M | 23% |
| Other | $33.8M | 8% |
| Other Business Segments | $10.2M | 2% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
